ICU Medical, Inc. reported $2.16B of revenue over the trailing twelve months, −9.0% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $2.16B (to Q2 2026). Net income: $30M, trailing twelve months to Q2 2026. Free cash flow: $153M, trailing twelve months to Q2 2026. Operating margin: 3.3%, trailing twelve months to Q2 2026.

ICUIICU Medical, Inc.

Healthcare

$166.65+43% 1Y

$166.65

$115.4552 weeks$187.34

ICUI as reported

ICU Medical, Inc. reported $2.16B of revenue over the trailing twelve months, −9.0% on the year before. 11 reported series are charted on this page, each one as filed.

$2.16B

Revenue, trailing twelve months · to Q2 2026 · −9.0% against the twelve months before

Net income: $30M
Net income · −181% year on year · trailing twelve months to Q2 2026
Free cash flow: $153M
Free cash flow · +153% year on year · trailing twelve months to Q2 2026
Operating margin: 3.3%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for ICUI, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$2.16B	−9.0%	Q2 2026
Net income	$30M	−181%	Q2 2026
EPS	$1.19	−178%	Q2 2026
Gross margin	39%	n/a	Q2 2026
Operating margin	3.3%	n/a	Q2 2026
Net margin	1.4%	n/a	Q2 2026
ROE	0.82%	n/a	Q2 2026
ROA	0.44%	n/a	Q2 2026
ROIC	1.5%	n/a	Q2 2026
Free cash flow	$153M	+153%	Q2 2026
P/E	140	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.